SC 13D Filing

Company

ELITE PHARMACEUTICALS INC /NV/

Filed

October 6, 2000

Accession Number

0000918905-00-000025

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →